Candi Nobles-James
Endocrinology, Diabetes & Metabolism · Macon, GANPI 1245316801
Payments from drug & device makers
Across 227 payments — averaging $25.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$764
- AstraZeneca$621
- Abbott$554
- Novo Nordisk$470
- Cvrx, Inc.$391
- Lilly USA, LLC$319
- plus $3K from 39 others
What the payments were for
- Speaking & faculty fees$75013%
- Food & beverage$5,03387%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t-slim insulin pump$750
- FARXIGA$373
- Barostim Neo System$271
- FFRct$180
- SPRAVATO$124
- LENVIMA$109
- FreeStyle Libre$109
How this compares
$5,797 in reported general payments places this provider in the 60th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
See all endocrinology, diabetes & metabolism providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $16,266 |
| SynthroidLevothyroxine Sodium | 13 | $1,277 |
| Levothyroxine Sodium | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $470 | $16,26615 claims |
| AbbVieSynthroid | $98 | $1,27713 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $52 | $7214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 222 endocrinology, diabetes & metabolism providers in Georgia.
Other endocrinology, diabetes & metabolism in Macon
- Thomas JonesMacon$4.8M
- Ashwini GoreMacon$2.6M
- Barry JohnsMacon$495K
- Bruce BodeAtlanta$18.3M
- Gulliermo UmpierrezAtlanta$6.6M
- John ReedRoswell$5.7M
- Steven LeichterColumbus$3.1M
- Jason BernerJasper$2.6M
- Adeniyi OdugbesanLawrenceville$1.8M
- David RobertsonAtlanta$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.